Results 131 to 140 of about 1,802,299 (400)

A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis [PDF]

, 2000
Joan M. Bathon, Richard W. Martin, Roy Fleischmann, John Tesser, Michael Schiff, Edward Keystone, Mark C. Genovese, Mary Chester Wasko, Larry W. Moreland, Arthur L. Weaver, Joseph A. Markenson, Barbara Finck   +11 more
openalex   +1 more source

Hip morphology‐based osteoarthritis risk prediction models: development and external validation using individual participant data from the World COACH Consortium

Arthritis Care &Research, Accepted Article.
Objectives This study aims to develop hip morphology‐based radiographic hip osteoarthritis (RHOA) risk prediction models and investigates the added predictive value of hip morphology measurements and the generalizability to different populations. Methods We combined data from nine prospective cohort studies participating in the World COACH consortium ...
Myrthe A. van den Berg, Fleur Boel, Michiel M.A. van Buuren, Noortje S. Riedstra, Jinchi Tang, Harbeer Ahedi, Nigel K. Arden, Sita M.A. Bierma‐Zeinstra, Cindy G. Boer, Flavia M. Cicuttini, Timothy F. Cootes, David T. Felson, Willem Paul Gielis, Joshua Heerey, Graeme Jones, Stefan Kluzek, Nancy E. Lane, Claudia Lindner, Joyce B.J. van Meurs, Andrea Mosler, Amanda E. Nelson, Michael C. Nevitt, Edwin H. Oei, Jos Runhaar, Harrie Weinans, Jesse H. Krijthe, Rintje Agricola   +26 more
wiley   +1 more source

Anterior cruciate ligament reconstruction simultaneously with trans-tibial pull-out fixation of avulsion fracture of medial and lateral meniscus posterior roots: a case report and eight-year follow-up

BMC Musculoskeletal Disorders
We report a rare case of anterior cruciate ligament (ACL) tear combined with acute avulsion fracture of the medial and lateral meniscal posterior roots in a 23-year-old male patient.
Yingchang Pang, Sibo Xu, Gengxian Xiang, Kaiqi Zhang, Tiezheng Sun   +4 more
doaj   +1 more source

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA) [PDF]

, 2013
Philip J. Mease, Roy Fleischmann, Atul Deodhar, J. Wollenhaupt, Majed Khraishi, D. Kielar, Franz Woltering, C. Stach, Bengt Hoepken, T. Arledge, Désirée van der Heijde   +10 more
openalex   +1 more source

An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis

Genome Medicine, 2016
The adaptive immune response in rheumatoid arthritis (RA) is influenced by an interaction between host genetics and environment, particularly the host microbiome.
Jun Chen, K. Wright, John M. Davis, P. Jeraldo, E. Marietta, J. Murray, Heidi Nelson, E. Matteson, V. Taneja   +8 more
semanticscholar   +1 more source

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis. [PDF]

, 2009
The approach to treating autoimmune disorders is currently undergoing a significant change in focus. As therapies are developed that are more precise in targeting the pathogenesis for these diseases, patients experience significantly fewer side effects ...
Sands, Jacob, Tuscano, Joseph M
core   +2 more sources

Physician Referral Patterns to Physical Therapists for Managing Knee Osteoarthritis: A Retrospective Analysis of Electronic Health Records from an Integrated Health System

Arthritis Care &Research, Accepted Article.
Objectives This study aims to describe the frequency and timing of physician referrals to physical therapists (PT) and other treatments prescribed over 12 months in patients with recent onset of knee osteoarthritis (KOA). The study also aims to identify determinants of early PT referrals.
Samannaaz S. Khoja, Joel M. Stevans, Gustavo J. Almeida, Clair Smith, Janet K. Freburger   +4 more
wiley   +1 more source

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate‐naive patients with active rheumatoid arthritis: Twenty‐four–week results of a phase III, multicenter, randomized, double‐blind, placebo‐controlled study of golimumab before methotrexate as first‐line therapy for early‐onset rheumatoid arthritis [PDF]

, 2009
Paul Emery, Roy Fleischmann, Larry W. Moreland, Elizabeth C. Hsia, Ingrid Strusberg, Patrick Durez, Peter Nash, Eric Amante, Melvin Churchill, Won Park, Bernardo A. Pons‐Estel, Mittie K. Doyle, Sudha Visvanathan, Weichun Xu, Mahboob U. Rahman   +14 more
openalex   +1 more source

Cost‐Effectiveness of Low‐Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start‐Low Go‐Slow” Approach for Gout: Evidence From a Noninferiority Randomized Double‐Blind Placebo‐Controlled Trial

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko, Ross Wilson, Nicola Dalbeth, J. Haxby Abbott, Lisa Stamp   +4 more
wiley   +1 more source

Disease activity flares and pain flares in an early rheumatoid arthritis inception cohort; characteristics, antecedents and sequelae

BMC Rheumatology, 2019
Background RA flares are common and disabling. They are described in terms of worsening inflammation but pain and inflammation are often discordant. To inform treatment decisions, we investigated whether inflammatory and pain flares are discrete entities.
Daniel F. McWilliams, Shimin Rahman, Richard J. E. James, Eamonn Ferguson, Patrick D. W. Kiely, Adam Young, David A. Walsh   +6 more
doaj   +1 more source